Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
CODEXIS, INC.Listing on record | Sell | $6M | Unusual size | SEC | |
CODEXIS, INC.Listing on record | Sell | $130.7K | SEC | ||
Aclaris Therapeutics, Inc.Listing on record | Sell | $83.2K | SEC | ||
Aclaris Therapeutics, Inc.Listing on record | Sell | $3.8M | SEC | ||
Aclaris Therapeutics, Inc.Listing on record | Sell | $66.1K | SEC | ||
Aclaris Therapeutics, Inc.Listing on record | Sell | $3M | SEC | ||
Aclaris Therapeutics, Inc.Listing on record | Sell | $130.1K | SEC | ||
Aclaris Therapeutics, Inc.Listing on record | Sell | $6M | Unusual size | SEC | |
Sierra Oncology, Inc.Listing unverified | Buy | $3.7M | conv 59ClusterFirst in 12mo | SEC | |
Sierra Oncology, Inc.Listing unverified | Buy | $79.8K | conv 54ClusterFirst in 12mo | SEC | |
Sierra Oncology, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Sierra Oncology, Inc.Listing unverified | Other | $556.7K | SEC | ||
Sierra Oncology, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Sierra Oncology, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Sierra Oncology, Inc.Listing unverified | Other | $12.1K | SEC | ||
Sierra Oncology, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Lite Strategy, Inc.Listing unverified | Sell | $6.3K | SEC | ||
Lite Strategy, Inc.Listing unverified | Sell | $323.3K | SEC | ||
Lite Strategy, Inc.Listing unverified | Sell | $2.1M | SEC | ||
Lite Strategy, Inc.Listing unverified | Sell | $1.8M | SEC |